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Abstract
Background: Symptoms of cancer may be interpreted differently by different patients before the diagnosis. This
study investigated symptom attributions in Danish patients with colorectal cancer and the potential associations
with symptom type, socio-demographic characteristics and patient interval.
Methods: Data were collected among incident colorectal cancer patients (n = 577, response rate 64.2 %), who were
asked to think back on the time before their diagnosis when completing the questionnaire. The questionnaire
comprised a Danish version of the revised Illness Perception Questionnaire (IPQ-R) with questions on 19 symptom
attributions. These 19 attribitutions were categorised into five causal groups for statistical analyses. The patient
interval (i.e. the time from the patient’s first symptom experience to presentation to the healthcare system) was
assessed in the same questionnaire. Data on socio-demographic characteristics were obtained by using nationwide
registers from Statistics Denmark.
Results: Patients who experienced ‘blood in stool’ as the most important symptom were more likely to attribute
this to cancer (PRad 1.94, 95 % CI 1.46-2.58) and benign somatic causes (PRad 1.36, 95 % CI 1.05-1.76), such as
haemorrhoids, compared to patients who did not perceive this symptom as the most important. Socio-demographic
characteristics were also associated with symptom attribution. Patients with higher educational levels were less likely to
attribute their most important symptom to psychological causes (PRad 0.57, 95 % CI 0.34–0.96) than patients with lower
educational levels. Patients with rectal cancer attributed their most important symptom to a benign somatic cause
more often than patients with colon cancer (PRad 1.34, 95 % CI 1.02–1.77).
Conclusions: Symptom attribution in patients was associated with aspects of socio-demography and with the
symptom type perceived by the patient as the most important. No significant associations were found between
symptom attributions and patient interval. These results have implications for general practice as symptom
attributions may prompt patients to present symptoms in a certain way and thereby influence the general
practitioner’s assessment of presented symptoms.
Background
Colorectal cancer (CRC) is the second most common can-
cer in Europe, both in terms of cancer incidence and cause
of cancer death [1], and the prognosis is dependent on
early diagnosis [2]. Thus, a key factor in improving the
survival is the promotion of early diagnosis.
More than 98 % of the Danish population is listed with
a general practitioner (GP) [3]. The GP is the first point
of contact in the healthcare system and is involved in
the initial diagnosis of approximately 85 % of all cancer
cases [4]. Therefore, early diagnosis of CRC is highly
dependent on the interaction between the patient’s inter-
pretation and presentation of symptoms and the GP’s re-
sponse to the presented symptoms [5].
The patient’s symptom interpretation depends on sev-
eral factors. Firstly, the specific symptom experienced by
the patient may influence the way that it is interpreted
by the patient, presented to others and which
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attributions are given to the symptom. One study re-
ported that a patient’s thoughts about a symptom may
vary according to the nature of that particular symptom,
and patients who experienced blood in stools were more
likely to fear that this was a symptom of cancer [6]. Sec-
ondly, some studies have found that people of low socio-
economic position (SEP) experience more difficulties with
interpreting health messages and may be less aware of
which symptoms to attribute to cancer than people with a
higher SEP [7]. Finally, the social context and the specific
situation can influence the way people attribute symptoms
to different explanations [7].
Previous studies have shown that the length of the pa-
tient interval, i.e. the time from the patient experiences
the first symptom until healthcare is sought [8], varies
among patients [4, 9]. Aspects associated with longer pa-
tient intervals include assumption that symptoms were
not serious, denial of symptoms, fear of serious illness
and lower levels of education [10].
Therefore, we need more knowledge about the pa-
tients’ thoughts about the symptoms presented to their
GP which later turned out to be signs of cancer. Such
knowledge can be obtained by studying the patients’
symptom attributions and identifying factors associated
with these attributions. This information may be useful
not only in future public health campaigns, but may also
impact the patient-GP encounter and the way that fur-
ther symptom investigation is established.
Consequently, the aims of this study were 1) to de-
scribe CRC patients’ attributions of their most important
symptom before presentation to the GP and 2) to iden-
tify associations between symptom attribution and type
of symptom, socio-demographic characteristics and the
patient interval.
Methods
Design and data collection
This study was carried out as a cross-sectional question-
naire study. All Danish citizens who had been registered
with an incident, histologically confirmed CRC in the
Danish Pathology Data Bank (DPDB) in the period from
1 January to 1 May 2010 were included. The DPDB is a
nationwide online database in which information on all
diagnostic cytological and histological specimens is reg-
istered by all Danish departments of pathology [11].
CRC patients were identified by applying the Danish ver-
sion of the Systematized Nomenclature of Medicine
(SNOMED) codes: T67*3 (colon), T68*3 (rectum) and
T73970 (ureter and colon).
Questionnaire data were collected between 12 July and
26 August 2010, and the questionnaires were sent out
3–7 months after diagnosis. In total, 1105 patients were
identified through the DPDB. Of these, 206 patients
(18.6 %) were excluded because of death, unknown
address or research protection (i.e. publicly recorded
protection against participation in research) [12]. Thus,
899 patients received a questionnaire. Non-respondents
received a reminder after three weeks, including a new
copy of the questionnaire. A total of 577 questionnaires
were completed and returned (response rate: 64.2 %).
The following groups of respondents were excluded
from the analysis: 8.1 % (n = 47) reported no preceding
symptoms of cancer before contacting a GP, 9.0 % (n = 52)
had experienced several symptoms, but not indicated the
most important one and 7.3 % (n = 42) had more than
50 % missing values in the questionnaire. In total, 48.5 %
(n = 436) patients of the original study population were in-
cluded in the statistical analyses.
Included variables
The questionnaire contained questions on the patient inter-
val [8]. This interval was calculated as the number of days
between first symptom experience and first GP encounter.
The questionnaire also comprised a Danish version of the
Revised Illness Perception Questionnaire (IPQ-R) [13], in-
cluding questions on symptoms and symptom attributions.
The respondents were asked to state the most import-
ant symptom they had experienced before healthcare
seeking in an open-ended question with the wording:
Which of the symptoms you experienced did you perceive
as the most important? The patients were then asked to
think of this symptom when answering the remaining
part of the questionnaire. If the patient stated two symp-
toms or more as their most important symptom, the first
symptom was regarded as the most important. The most
important symptoms reported by the patients were cate-
gorised into the following four groups: blood in stool,
abdominal pain, change in bowel habits and other symp-
toms. These were coded as ‘yes’ if the patient assessed
the symptom as the most important and ‘no’ if not. To
reduce the number of categories, some of the stated
symptoms were combined. Diarrhoea and constipation
were combined into change in bowel habits. Symptoms
such as fatigue (n = 54), decreased appetite (n = 35), nau-
sea (n = 19) and fever (n = 12) were combined into other
symptoms since few persons stated these as the most im-
portant symptom.
The patients were also asked to state the causes they
attributed to their most important symptom. Thus, in
contrast to the original IPQ-R, patients were here asked
to identify the perceived causes of their symptom as dis-
tinct from the causes of their illness. A more detailed de-
scription of the changes of the IPQ-R is found elsewhere
[13]. The questionnaire listed 19 possible causes of the
symptom; the patient was asked to rate each of these on a
5-point Likert scale. For analyses, we categorised the 19
causes into ‘agree’ (comprising the categories ‘strongly
agree’ and ‘agree’) and ‘disagree’ (comprising the categories
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‘strongly disagree’, ‘disagree’ and ‘neither agree nor dis-
agree’). The 19 causes were divided into the following five
groups for this study: 1. Cancer, 2. Benign somatic causes
(comprising the following attributes: a germ or virus; al-
tered immunity; already diagnosed disease; haemorrhoids;
and scratch or cut), 3. Psychological causes (comprising
the following attributes: worry; stress; my emotional
state, e.g. feeling down, lonely, anxious, empty; family
worry or problems; and overwork), 4. Lifestyle-related
causes (comprising the following attributes: diet; my
own behaviour; smoking; and alcohol), 5. Causes be-
yond individual control (comprising the following attri-
butes: accident or injury; hereditary—it runs in my
family; ageing; and chance or bad luck).
Register data
These data were linked at the individual level using the
unique civil registration number possessed by all Danish
residents [14] and combined with information on the pa-
tients’ socio-demographic characteristics obtained from
Statistics Denmark [15]. The following variables were in-
cluded: age (≤64, 65+), gender (male, female), marital sta-
tus (married/cohabiting, living alone) and highest achieved
educational level (low: ≤10 years, middle: >10 ≤ 15 years
and high: >15 years) according to UNESCO’s International
Standard Classification of Education (ISCED) [16].
Ethical considerations
The project was approved by the Danish Data Protection
Agency (file no. 2009-41-3471). Because the study was
based on registry and survey data, no ethical approval
was required.
Statistical analyses
The statistical analyses were performed using Stata ver-
sion 13.1. Proportions were calculated to estimate the
frequency of the most important symptom for patients
before healthcare seeking. To study the relationship be-
tween the most important symptom and the five symp-
tom attribution groups, we conducted generalised linear
models (GLM) [17, 18] with prevalence ratios (PRs) and
95 % confidence intervals (CIs). An unadjusted model
was produced and followed by a model adjusted for age,
gender, marital status and education. The same method
was applied to study the association between socio-
demographic characteristics and the different symptom
attribution groups. Furthermore, we studied attribution
groups by cancer site divided into rectal and colon
cancer.
The association between the five attribution groups
and the patient interval was also analysed using an un-
adjusted GLM model and a GLM model adjusted for
gender, age, marital status and education. The cut-off
point for short vs long patient interval was 88 days
generated from the 75th percentile from first symptom
experience until healthcare seeking.
Results
Socio-demographic characteristics of respondents
The mean age of the respondents included in the ana-
lyses (n = 436) was 67.7 years; 55.7 % were males, 68.8 %
were either married or cohabiting and 18.1 % had 15 or
more years of education. In total, 279 were diagnosed
with colon cancer, 133 with rectal cancer and 24 with
both cancer types either because the patient had cancer
in both colon and rectum and/or because the tumour
was located in the transitional zone between the two
(data not shown). The distribution of socio-demographic
characteristics, symptom type and cancer type is pre-
sented by the five causal groups in Table 1.
Most important symptom and attributed causes
The majority of the respondents stated blood in stool as
the most important symptom (32.8 %), followed by
changes in bowel habits (28.9 %), other symptom (22.0 %)
and abdominal pain (16.3 %) (data not shown).
Table 2 presents the association between the most im-
portant symptom and the five symptom attribution
groups. Respondents who stated blood in stool as the
most important symptom were statistically significantly
more likely to attribute this symptom to cancer (PRad
1.94, 95 % CI 1.46–2.58) or to benign somatic causes
(PRad 1.36, 95 % CI 1.05-1.76) than respondents who did
not report blood in stool as the most important symp-
tom. Among respondents who reported abdominal pain
as the most important symptom, statistically significantly
more respondents attributed this symptom to lifestyle-
related causes (PRunad 1.43, 95 % CI 1.04–1.95) and statis-
tically significantly fewer respondents attributed this
symptom to benign somatic causes (PRunad 0.70, 95 % CI
0.52–0.93). However, only the latter association remained
statistically significant after adjustment. Respondents with
other symptoms were statistically significantly more likely
not to attribute their symptoms to cancer or to benign
somatic causes. However, the latter finding was only statis-
tically significant in the unadjusted analysis.
Socio-demographic characteristics and causes attributed
to the symptom
Respondents aged 65 years or older were found to be
statistically significantly less likely than respondents aged
less than 65 years to attribute their symptom to psycho-
logical causes (PRad 0.70, 95 % CI 0.50–0.98) and
lifestyle-related causes (PRad 0.67, 95 % CI 0.47–0.95).
Respondents with rectal cancer were more likely to be-
lieve that their symptom was due to a benign somatic
cause, such as haemorrhoids, scratch or cut (PRad 1.34,
95 % CI 1.02–1.77).
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Respondents with high educational levels were statisti-
cally less likely than respondents with low educational
levels to attribute their symptom to psychological causes
(PRad 0.57, 95 % CI 0.34–0.96). It should be noted that
attributing symptoms to cancer was not statistically sig-
nificantly associated with any of the socio-demographic
characteristics (Table 3).
Symptom attributions and patient interval
Table 4 shows the association between the five symptom
attribution groups and a long patient interval. There was
a tendency that an attribution to a benign somatic dis-
ease was associated with longer patient intervals, but the
association did not reach statistical significance (PRad
1.40, 95 % CI 0.95–2.06).
Discussion
Main results
The symptom ‘blood in stool’ was most often mentioned
as the most important symptom. However, non-specific
symptoms like fatigue, nausea, fever and decreased appe-
tite were stated as the most important symptom by ap-
proximately one in four of all respondents. We found
significant associations between the symptoms perceived
as the most important and the attributions given to
these symptoms. For example, patients who reported
their most important symptom to be blood in stool were


















Male 33.1 (80) 242 58.6 (137) 234 30.3 (73) 241 33.9 (81) 239 55.5 (132) 238
Female 26.2 (50) 191 59.7 (109) 183 42.6 (81) 190 30.0 (56) 187 59.5 (110) 185
Age
≤64 28.1 (43) 153 68.7 (103) 150 41.8 (64) 153 39.1 (59) 151 54.7 (82) 150
65+ 31.1 (87) 280 53.6 (143) 267 32.4 (90) 278 28.9 (78) 275 58.6 (160) 273
Marital status
Married/coh. 29.1 (87) 299 58.7 (169) 288 32.9 (98) 298 30.0 (88) 293 58.2 (171) 294
Living alone 32.1 (43) 134 59.7 (77) 129 42.1 (56) 133 36.8 (49) 133 55.0 (71) 129
Education
Short 28.6 (42) 147 46.8 (66) 141 43.2 (63) 146 35.2 (51) 145 61.5 (88) 143
Middle 31.3 (62) 198 67.0 (126) 188 33.5 (66) 197 29.0 (58) 193 57.7 (112) 194
High 28.6 (22) 77 63.6 (49) 77 26.0 (20) 77 35.1 (27) 77 48.0 (36) 75
Cancer type
Colon 28.6 (79) 276 51.1 (135) 264 37.8 (104) 275 32.8 (89) 271 58.9 (159) 270
Rectal 31.6 (42) 133 72.1 (93) 129 31.8 (42) 132 31.3 (41) 131 53.5 (69) 129
Blood in stool
Yes 44.1 (63) 143 71.9 (100) 139 32.2 (46) 143 26.2 (37) 141 60.0 (84) 140
No 23.1 (67) 290 52.5 (146) 278 37.5 (108) 288 35.1 (100) 285 55.8 (158) 283
Abdominal pain
Yes 22.9 (16) 70 43.1 (28) 65 41.4 (29) 70 42.9 (30) 70 55.9 (38) 68
No 31.4 (114) 363 61.9 (218) 352 34.6 (125) 361 30.1 (107) 356 57.5 (204) 355
Change in bowel habits
Yes 26.4 (33) 125 63.4 (78) 123 36.0 (45) 125 36.3 (45) 124 55.7 (68) 122
No 31.5 (97) 308 57.1 (168) 294 35.6 (109) 306 30.5 (92) 302 57.8 (174) 301
Other symptomsa
Yes 19.0 (18) 95 44.4 (40) 90 36.6 (34) 93 27.5 (25) 91 55.9 (52) 93
No 33.1 (112) 338 63.0 (206) 327 35.5 (120) 338 33.4 (112) 335 57.6 (190) 330
Bold font represents statistically significant differences between groups p < .05 (chi2)
aSymptoms such as fatigue, nausea, fever and decreased appetite
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Table 2 Prevalence ratiosa and 95 % CI of most important symptom and the five symptom attributions
Cancer Benign somatic causes Psychological causes Lifestyle-related causes Causes beyond
individual control
Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted
Blood in stool
No 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Yes 1.91 (1.44–2.52) 1.94 (1.46–2.58) 1.37 (1.18–1.60) 1.36 (1.05–1.76) 0.86 (0.65–1.14) 0.89 (0.68–1.18) 0.75 (0.54–1.03) 0.76 (0.52–1.11) 1.07 (0.91–1.27) 1.10 (0.93–1.30)
Abdominal pain
No 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Yes 0.73 (0.46–1.15) 0.76 (0.48–1.20) 0.70 (0.52–0.93) 0.65 (0.44–0.97) 1.20 (0.88–1.64) 1.06 (0.70–1.61) 1.43 (1.04–1.95) 1.26 (0.83–1.92) 0.97 (0.77–1.22) 0.97 (0.77–1.22)
Change in bowel habits
No 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Yes 0.84 (0.60–1.17) 0.80 (0.57–1.13) 1.11 (0.94–1.31) 1.10 (0.87–1.45) 1.01 (0.77–1.33) 1.02 (0.72–1.46) 1.19 (0.89–1.59) 1.24 (0.86–1.78) 0.96 (0.80–1.16) 0.96 (0.80–1.16)
Other symptomsb
No 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Yes 0.57 (0.37–0.89) 0.54 (0.33–0.86) 0.71 (0.55–0.90) 0.75 (0.53–1.05) 1.03 (0.76–1.40) 1.05 (0.71–1.56) 0.82 (0.57–1.19) 0.86 (0.54–1.35) 0.97 (0.79–1.19) 0.94 (0.76–1.16)
*Numbers in bold are significant results
aAdjusted for age, gender, marital status and education













Table 3 Prevalence ratiosa and 95 % CI of socio-demographic characteristics and the five symptom attributions
Cancer Benign somatic causes Psychological causes Lifestyle-related causes Causes beyond
individual control
Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted
Gender
Male 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Female 0.79 (0.59–1.07) 0.79 (0.80–1.51) 1.02 (0.87–1.19) 1.03 (0.79–1.33) 1.41 (1.09–1.81) 1.34 (0.95–1.84) 0.88 (0.67–1.17) 0.79 (0.56–1.13) 1.07 (0.91–1.26) 1.07 (0.82–1.39)
Age
≤64 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)




1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Living alone 1.10 (0.81–1.49) 1.16 (0.84–1.59) 1.02 (0.86–1.21) 1.05 (0.79–1.39) 1.28 (0.99–1.66) 1.17 (0.83–1.65) 1.23 (0.92–1.63) 1.27 (0.88–1.83) 0.95 (0.79–1.14) 0.90 (0.67–1.21)
Education
Low 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Middle 1.10 (0.79–1.52) 1.09 (0.78–1.52) 1.43 (1.17–1.75) 1.39 (1.03–1.89) 0.78 (0.59–1.02) 0.76 (0.54–1.09) 0.82 (0.60–1.13) 0.77 (0.52–1.13) 0.94 (0.79–1.12) 0.94 (0.70–1.25)
High 1.00 (0.65–1.55) 1.01 (0.65–1.57) 1.36 (1.07–1.73) 1.30 (0.89–1.90) 0.60 (0.40–0.92) 0.57 (0.34–0.96) 1.00 (0.68–1.45) 0.91 (0.56–1.47) 0.78 (0.60–1.02) 0.780 (0.53–1.16)
Cancer site
Colon 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Rectal 1.10 (0.81–1.51) 1.05 (0.76–1.46) 1.41 (1.20–1.65) 1.34 (1.02–1.77) 0.84 (0.63–1.13) 0.83 (0.57–1.21) 0.95 (0.70–1.29) 0.84 (0.58–1.24) 0.91 (0.75–1.10) 0.92 (0.68–1.24)
*Numbers in bold are significant results













more likely to attribute this to cancer or benign somatic
causes than patients who did not assess blood in stool as
the most important symptom. Having rectal cancer was as-
sociated with a benign attribution. Patients aged 65 years or
older were less likely to attribute symptoms to lifestyle or
psychological explanations, and patients with lower educa-
tional levels were more likely to attribute their symptom to
psychological causes. A long patient interval tended to be
associated with attribution to benign explanations, although
this propensity was not statistically significant.
Discussion of results
In line with another study [19], we found that a non-
specific symptom is commonly seen as one of the first
signs among cancer patients. Studies indicate that non-
specific symptoms like fatigue and weight loss are harder
for patients to interpret than specific alarm symptoms
like a lump in the breast [20, 21]. This difference is also
supported by this study showing that patients with the
more non-specific symptoms (classified into the category
‘other symptoms’) were more likely not to attribute these
symptoms to cancer.
Experiencing blood in stool as the most important
symptom before seeking medical advice was associated
with attributing the symptom to cancer in this study,
which was also found in another Danish study [6]. How-
ever, we also found that statistically significantly more
patients with blood in stool attributed this to benign
somatic causes (e.g. haemorrhoid, scratch or cut). This
finding is in line with the results of another study, which
found that the majority of cancer patients initially attri-
bute their symptoms to other illnesses than cancer; more
than 50 % attribute their symptoms to haemorrhoids
[22]. Blood in stool is a common symptom [23] which is
often causen by e.g. haemorrhoids. Thus, attributing
blood in stool to haemorrhoids may be common sense.
Hence, a review on symptom representations found that
attributing cancer symptoms to other ailments than can-
cer is common among cancer patients [24]. These re-
sults indicate that some cancer patients did attribute
their initial symptoms to cancer, but other patients attri-
bute their symptoms to something else; this applies both
to patients with specific and non-specific symptoms.
The crucial challenge for patients is to distinguish be-
tween benign and malignant symptoms [24]. Several
studies have found that many people are not aware of
the symptoms associated with colorectal cancer [25–27].
However, the implications for public health campaigns
are complex. On the one hand, it is an important mes-
sage for the population that symptoms such as blood in
stool and more non-specific symptoms like persistent fa-
tigue and weight loss could be due to cancer. On the
other hand, fear of cancer has also shown to increase the
risk of long patient intervals [28]. Moreover, GPs would
probably not be able to accommodate the extra work-
load if every person with rectal bleeding and fatigue im-
mediately presented these symptoms to their GP.
It is well established that people with a higher educa-
tional level and higher income are more likely to have bet-
ter health outcomes [29, 30]. It has also previously been
found that people with a high SEP are more likely to seek
medical help faster than people with a low SEP [31, 32].
This study also indicates that symptom attributions
among cancer patients before diagnosis vary between
socio-demographic groups. For example, patients with
lower educational levels were more likely to attribute their
symptom to psychological causes than patients with
higher educational levels, whereas patients aged 65 years
or older were less likely to attribute their symptom to psy-
chological and lifestyle-related causes than patients aged
64 years or younger. This variation across socio-
demographic groups may be valuable knowledge for GPs
because patients bring their own interpretations of their
symptoms when these are presented to a medical profes-
sional. Our study indicates that among patients who later
got CRC, the GP can meet patients who are ‘normalising’
their symptom and attributing it to a benign explanation
when presenting their symptom in the medical consult-
ation. This is a valuable insight, which must be kept in
mind in the clinical encounter.
No statistically significant associations were observed
between symptom attributions and the patient interval.
Still, there was a tendency that attribution to benign dis-
ease leads to longer patient intervals.
Table 4 Prevalence ratiosa and 95 % CI for association between
long interval and the five symptom attributions
Prevalence ratio for having a long patient interval (i.e. ≥ 88 days)
Unadjusted Adjusted
Cancer
Disagree 1 (ref.) 1 (ref.)
Agree 0.76 (0.51–1.13) 0.77 (0.51–1.15)
Benign somatic causes
Disagree 1 (ref.) 1 (ref.)
Agree 1.40 (0.96–2.03) 1.40 (0.95–2.06)
Psychological causes
Disagree 1 (ref.) 1 (ref.)
Agree 1.23 (0.87–1.74) 1.25 (0.88–1.79)
Lifestyle-related causes
Disagree 1 (ref.) 1 (ref.)
Agree 1.20 (0.84–1.71) 1.11 (0.77–1.59)
Causes beyond individual control
Disagree 1 (ref.) 1 (ref.)
Agree 0.99 (0.70–1.41) 1.02 (0.72–1.45)
aAdjusted for age, gender, marital status and education
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Discussion of methods
To the best of our knowledge, this study is the first to
deploy a theoretical framework (i.e. Leventhal’s Common
Sense model and the IPQ-R [33]) to examine symptom
attributions before a CRC diagnosis. We consider this a
key strength. Various data sources were used in this
study, and the application of the unique Danish civil
registration number [14] enabled us to link all data
sources. The CRC patients were identified through the
DPDB, which has previously been validated and found
to be a reliable tool [11]. However, registrations prior to
1997 were incomplete. This imples that some recurrent
cancers might be present, and it is likely that the symp-
tom attribution and healthcare-seeking behaviour of re-
current cancer patients is distinct from that of incident
cancer patients. Variables on socio-demographic charac-
teristics were obtained from national registers containing
valid individual-specific information [34]. Our response
rate of 64.2 % is higher than in comparable studies for
this population (i.e. diagnosed cancer patients) [6, 35].
Moreover, from a previous study on this population, we
know that non-respondents tend to be significantly older
than respondents [13].
The information about the patients’ most important
symptom, symptom attributions and patient interval was
obtained by a questionnaire, and the appropriateness of
this method could be discussed. Each patient was asked
to state the most important symptom experienced prior
to help-seeking and to think of this symptom when an-
swering the IPQ-R. This was done as patients with sev-
eral symptoms may have had different interpretations to
each of the symptoms making the questionnaire impos-
sible to complete. This has two important implications.
Firstly, the reference group used for comparison with
each of the four symptom groups comprises patients
who did not assess the symptom as the most important,
i.e. the symptom may have been experienced although
not assessed as the most important one. This was e.g.
the case for 21 % of the patients who did not assess their
most important symptom to be blood in stool, but they
still reported to have experienced this symptom. Sec-
ondly, although we intended to study the most import-
ant symptom as perceived by the patient, several other
symptoms might also have been experienced by the pa-
tient. These symptoms may have interacted and created
different reactions in combination (e.g. patients with
both blood in stool and changes in bowel habits may
think differently about their symptoms than patients
with fatigue and changes in bowel habits). Future studies
should examine more thoroughly the complex interac-
tions between frequently occurring symptom combina-
tions and attributed causes.
Another crucial point is that we aimed to study symp-
tom attributions prior to diagnosis among a group of
already diagnosed patients. Hence, we relied on the pa-
tients’ ability to distinguish between their symptom ex-
periences before and after becoming a cancer patient. As
patients will often try to rationalise and legitimate their
decision to seek care [36], a retrospective design may
introduce recall bias as also pointed out by several
former studies [37, 38]. However, other study designs
may also introduce methodological challenges. It would
be unfeasible to follow a large population in a prospect-
ive design and continuously study their symptom experi-
ences in detail because only very few will develop cancer
and thus be eligible for study. Thus, although the applied
design has limitations, it may be the only feasible
method. Several points indicate that the patients were
not affected by the retrospective assessments of symp-
toms and help-seeking behaviour. Firstly, we validated
the psychometric properties of symptom attribution as a
construct in this patient group [13]. This validation indi-
cated that a small proportion of patients were thinking
of their disease instead of their symptom when answer-
ing the questionnaire [13]. We also found that experien-
cing the alarm symptom ‘blood in stool’ as the most
important symptom was associated with both attributing
this to cancer and to a benign somatic cause. This could
indicate that the patients did not answer in one direction
because they were now aware that the symptoms were
due to cancer.
Among our study population, 279 were diagnosed with
colon cancer, 133 with rectal cancer and 24 with both
cancer types. This distribution reflects the overall inci-
dence in Denmark, where about two thirds of all colo-
rectal tumours develop in the colon [39]. Patients with
colon cancer often present with vague symptoms such
as weight loss and fatigue, whereas cancer located in the
rectum often causes symptoms like abnormal defecation
with blood or mucus [40]. As patients with these cancer
types seem to experience different symptoms, at least to
some degree, this may have affected our results because
symptom attributions are associated with the most im-
portant symptom experienced.
Conclusions
This study provided insights into CRC patients’ attribu-
tions of their most important symptom prior to their
diagnosis and into factors associated with these attribu-
tions. The results indicate that patients who assessed
their most important symptom to be blood in stool were
more likely to attribute this to cancer or to a benign
somatic cause and that patients with low educational
levels were more likely to attribute their symptom to
psychological causes. This is important information as
false symptom interpretations may impact the patient-
GP encounter and may have later implications for the
Jensen et al. BMC Family Practice  (2015) 16:115 Page 8 of 10
timespan from symptom presentation to referral for
further investigations.
However, more research is needed in this area. It
could be valuable to examine the consequences of
self-labelling (i.e. the patient tells the GP what they
thinks is the most likely diagnosis, which may or may
not be correct) [41] for the clinical decision-making, for
the time spent in primary care and ultimately for the
diagnosis of CRC.
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